These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 29035827)

  • 21. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation.
    Hao J; Yang X; Ding XL; Guo LM; Zhu CH; Ji W; Zhou T; Wu XZ
    Sci Rep; 2016 Sep; 6():32809. PubMed ID: 27609096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
    Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
    Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin and erlotinib synergize to inhibit basal breast cancer.
    Lau YK; Du X; Rayannavar V; Hopkins B; Shaw J; Bessler E; Thomas T; Pires MM; Keniry M; Parsons RE; Cremers S; Szabolcs M; Maurer MA
    Oncotarget; 2014 Nov; 5(21):10503-17. PubMed ID: 25361177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1.
    Li J; Qi Y
    Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of ginsenoside Rg3 on lung injury in diabetic rats.
    Wang H; Wu W; Wang G; Xu W; Zhang F; Wu B; Tian Y
    J Cell Biochem; 2019 Mar; 120(3):3323-3330. PubMed ID: 30362612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
    Yang X; Zou J; Cai H; Huang X; Yang X; Guo D; Cao Y
    Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 20-(s)-ginsenoside Rg3 induces apoptotic cell death in human leukemic U937 and HL-60 cells through PI3K/Akt pathways.
    Qiu XM; Bai X; Jiang HF; He P; Wang JH
    Anticancer Drugs; 2014 Oct; 25(9):1072-80. PubMed ID: 25035959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.
    Lu YY; Jing DD; Xu M; Wu K; Wang XP
    World J Gastroenterol; 2008 Sep; 14(35):5403-11. PubMed ID: 18803351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer.
    Qi W; Cooke LS; Stejskal A; Riley C; Croce KD; Saldanha JW; Bearss D; Mahadevan D
    BMC Cancer; 2009 May; 9():142. PubMed ID: 19432987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy.
    Sui H; Shi C; Yan Z; Li H
    Drug Des Devel Ther; 2015; 9():3183-90. PubMed ID: 26124641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ginsenoside Rg5 induces apoptosis and autophagy via the inhibition of the PI3K/Akt pathway against breast cancer in a mouse model.
    Liu Y; Fan D
    Food Funct; 2018 Nov; 9(11):5513-5527. PubMed ID: 30207362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic.
    Pu Z; Ge F; Wang Y; Jiang Z; Zhu S; Qin S; Dai Q; Liu H; Hua H
    Bioengineered; 2021 Dec; 12(1):2398-2409. PubMed ID: 34130594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway.
    Liu H; Zhao J; Fu R; Zhu C; Fan D
    PLoS One; 2019; 14(5):e0216759. PubMed ID: 31091245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer.
    Li P; Zhang Q; Torossian A; Li ZB; Xu WC; Lu B; Fu S
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e391-7. PubMed ID: 22414288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ginsenoside Rg3-induced EGFR/MAPK pathway deactivation inhibits melanoma cell proliferation by decreasing FUT4/LeY expression.
    Shan X; Aziz F; Tian LL; Wang XQ; Yan Q; Liu JW
    Int J Oncol; 2015 Apr; 46(4):1667-76. PubMed ID: 25672851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ginsenoside Rk1 induces cell cycle arrest and apoptosis in MDA-MB-231 triple negative breast cancer cells.
    Hong Y; Fan D
    Toxicology; 2019 Apr; 418():22-31. PubMed ID: 30797898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor.
    Joo EJ; Chun J; Ha YW; Ko HJ; Xu MY; Kim YS
    Chem Biol Interact; 2015 May; 233():25-34. PubMed ID: 25824408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights into erlotinib action in pancreatic cancer cells using a combined experimental and mathematical approach.
    Lange F; Rateitschak K; Kossow C; Wolkenhauer O; Jaster R
    World J Gastroenterol; 2012 Nov; 18(43):6226-34. PubMed ID: 23180942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.